Analysis of Dose-Distribution in Left-Lung and Heart as Increasing the Number of Beams in Left-Sided Breast Irradiation

Document Type : Original Paper


1 Dr.C.V.Raman University,Kota,Bilaspur(C.G.)

2 Dr.C.V.Raman University,Kota,Bilaspur (C.G.)

3 Bhabha Atomic Research Centre,Mumbai, India

4 Applied Physics Department, Amity University Gwalior(M.P.),India

5 Indira Gandhi Institute of Medical Science,Patna,Bihar,India


Introduction:Breast cancer has been a leading malignancy in women across the globe. In breast conserving treatment, radiation therapy plays an important role. This is clinically approved that breast conserving surgery followed by adjuvant radiation therapy produces as the same survival rate as radical breast RT. The aim of this study was to find out suitable number of IMRT fields to treat left-sided breast cancer and analyze the effects of increasing the number of fields in IMRT plans.
Material and Methods:We selected 105 patients retrospectively for this study diagnosed with left-sided breast cancer of age ranging from 33 to 74 years.  There were 52 cases of chest wall (CW) irradiation including SCF, 20 cases of BCS and 33 cases were of CW including supra-clavicular fossa (SCF) and internal mammary lymph nodes (IMLN).
Results:Our main objective was to analyze dose-distribution of left lung. Monitor Units (MUs) were also recorded and found almost same in these three modalities ranging from 1200 to 2000. The mean value of V20Gy(cc) in 11-bIMRT technique was found less by 8-17cc as compared to 7-and 9-bIMRT technique. It was observed that 11-bIMRT technique yielded slightly better outcomes in terms of V20Gy(cc).
Conclusion: The technique 7-bIMRT gives slightly better result in controlling low-dose volume of underlying lung and heart. As the number of IMRT beams increases, it translates into better outcomes in terms of reducing high-dose volume as well as mean-dose of left lung. So, it is prudent to use ‘N’ number of IMRT fields such as 7≤ N ≤11 in left breast RT.


Main Subjects

  1. Simonetto C, Eidemüller M, Gaasch A, Pazos M, Schönecker S, Reitz D, et al. Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy. Radiotherapy and Oncology. 2019 Feb 1;131:202-7.
  2. Kaidar-Person O, Offersen BV, Poortmans P. Should risk-adapted delineation considered de-escalation of therapy? The ESTRO-ACROP radiation therapy guidelines after implant-based immediate reconstruction for early stage breast cancer. Radiother Oncol. 2019;141:327–
  3. Schönecker S, Walter F, Freislederer P, Marisch C, Scheithauer H, Harbeck N, et al. Treatment planning and evaluation of gated radiotherapy in left-sided breast cancer patients using the Catalyst TM/Sentinel TM system for deep inspiration breath-hold (DIBH). Radiation oncology. 2016 Dec;11:1-0.
  4. Trivedi SJ, Choudhary P, Lo Q, Sritharan HP, Iyer A, Batumalai V, et al. Persistent reduction in global longitudinal strain in the longer term after radiation therapy in patients with breast cancer. Radiotherapy and Oncology. 2019 Mar 1;132:148-54.
  5. Cai G, Cao L, Kirova YM, Feng Y, Chen JY. Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer. Radiat Oncol. 2019;14:115.
  6. Haussmann J, Budach W, Tamaskovics B, Bölke E, Corradini S, Djiepmo-Njanang FJ, et al. Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis. Radiation Oncology. 2019 Dec;14:1-4.
  7. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conservingsurgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347: 1227-32.
  8. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New Engl J Med. 2002; 347: 1233-41.
  9. Njeh CF, Saunders MW, Langton CM. Accelerated partial breast irradiation using external beam conformal radiation therapy: a review. Crit Rev Oncol Hematol. 2012; 81: 1-20.
  10. Hille-Betz U, Vaske B, Michael Bremer MD, Philipp Soergel MD, Kundu S, Klapdor R, et al. Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy. Strahlentherapie und Onkologie. 2016;192(1):8.
  11. Polgár C, Van Limbergen E, Pötter R, Kovács G, Polo A, Lyczek J, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010; 94: 264-73.
  12. Coles CE, Brunt AM, Wheatley D, Mukesh MB, Yarnold JR. Breast radiotherapy: less is more? Clin Oncol (R Coll Radiol). 2013; 25: 127-34.
  13. Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase-3 randomised controlled trial. Eur J Cancer. 2015; 51: 451-63.
  14. Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005; 23: 1726-35.
  15. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg. 2009; 209:269-77.
  16. Ansari S, Kumar Satpathy S. Half Beam Block Technique in Breast Cancer and It’s Dosimetric Analysis using different Algorithms. Iran J Med Phys. 2017; 14: 66-74.
  17. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death. Meta-analysis of individual patient data for 10 801women in 17 randomized trials. Lancet. 2011;378(9804):1707–
  18. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V et al. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005 Dec 17;366(9503):2087-106. doi: 10.1016/S0140-6736(05)67887-7. PMID: 16360786.
  19. Overgaard M, Jensen MB, Overgaard J, Hansen P, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen. Danish breast Cancer cooperative groupDBCG 82c randomized trial. Lancet. 1999;353(9165):1641–
  20. Darby S, Ewertz M, McGale P, Bennet A, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breastcancer. N Engl J Med. 2013;368(11):987–
  21. Darby S, McGale P, Taylor C, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer. Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557–
  22. Vicini F, Sharpe M, Kestin L, Martinez A. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:1336–
  23. Kestin LL, Sharpe MB, Frazier RC, Vicini FA, Yan D, Matter RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. International Journal of Radiation Oncology* Biology* Physics. 2000 Dec 1;48(5):1559-68.
  24. Ha B, Suh HS, Lee J, Lee KJ, Lee R, Moon BI. Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer. Radiat Oncol J. 2013;31(4):191–
  25. Mukesh B, Barnett GC, Wilkinson JS, Moody AM, Wilson C, Dorling L, et al. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer. 5-year results confirm superior overall cosmesis. J Clin Oncol.2013;31(36):4488–
  26. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Lancet. 2011;378(9804):1707–
  27. Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99(5):365–
  28. Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108(1):179–
  29. Morgan EA, Kozono DE, Wang Q, Mery CM, Butrynski JE, Baldini EH, et al. Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Oncol. 2012;19(12):3801–
  30. Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E. Mortality from myocardial infarction following post lumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys. 1999;43(4):755–
  31. Nielsen M, Berg M, Pedersen A, Andersen K, Glavicic V, Jakobsen E, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy ofearly breast cancer. National guidelines and contouring atlas by the Danish breast Cancer cooperative group. Acta Oncol (Stockholm, Sweden). 2013;52(4):703–
  32. Radiation therapy oncology group. Breast cancer atlas for radiation therapy planning: consensus definitions. 2009. Available from:
  33. Meattini I, Saieva C, Marrazzo L, Di Brina L, Pallotta S, Mangoni M, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial. Breast cancer research and treatment. 2015 Oct;153:539-47.
  34. Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. Journal of Clinical Oncology. 2008 May 1;26(13):2085-92.
  35. Pignol JP, Truong P, Rakovitch E, Sattler MG, Whelan TJ, Olivotto IA. Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial. Radiother Oncol. 2016;121:414–
  36. Mukesh MB, Qian W, Wilkinson JS, Dorling L, Barnett GC, Moody AM, et al. Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trial. Radiotherapy and Oncology. 2014 May 1;111(2):270-5.
  37. Sardaro A, Petruzzelli MF, D'Errico MP, Grimaldi L, Pili G, Portaluri M. Radiation-induced cardiac damage in early left breast cancer patients. Riskfactors, biological mechanisms, radiobiology, and dosimetric constraints.Radiother Oncol. 2012;103(2):133–
  38. Mege A, Zioueche A, Pourel N, Chauvet B. Radiation-related heart toxicity. Cancer Radiother. 2011;15(6–7):495–
  39. Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018 Feb 20;137(8):e30-66.
  40. Dumane VA, Saksornchai K, Zhou Y, Hong L, Powell S, Ho AY. Reduction inlow-dose to normal tissue with the addition of deep inspiration breath hold (DIBH) to tangential volumetric modulated arc therapy (TVMAT) in breast cancer patients with implant reconstruction receiving regional nodal irradiation. Radiat Oncol. 2018;13(1):187.

41. Dorr W, Herrmann T. Second primary tumors after radiotherapy for malignancies. Treatment-related parameters. Strahlenther Onkol. 2002;178(7):357–62.